Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Psoriasis/chemically induced"'
Publikováno v:
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, Vol 75, Iss 4 (2018)
Docetaxel is a second-generation taxane commonly used in the treatment of advanced malignant tumours such as breast adenocarcinoma. We describe the case of a 67-year-old female undergoing adjuvant chemotherapy with docetaxel for invasive ductal carci
Externí odkaz:
https://doaj.org/article/cb389620ff3e4df5a166077c373d534d
Autor:
Sam Polesie, Martin Gillstedt, Sigrún Alba Jóhannesdóttir Schmidt, Alexander Egeberg, Anton Pottegård, Kasper Kristensen
Publikováno v:
Polesie, S, Gillstedt, M, Schmidt, S A J, Egeberg, A, Pottegard, A & Kristensen, K B 2020, ' Use of methotrexate and risk of skin cancer: A nationwide case-control study ', Pharmacoepidemiology and Drug Safety, vol. 29, no. Suppl. 3, 3965, pp. 463 . < https://doi.org/10.1002/pds.5114 >
University of Southern Denmark
Polesie, S, Gillstedt, M, Schmidt, S A J, Egeberg, A, Pottegård, A & Kristensen, K 2023, ' Use of methotrexate and risk of skin cancer : a nationwide case-control study ', British Journal of Cancer, vol. 128, no. 7, pp. 1311-1319 . https://doi.org/10.1038/s41416-023-02172-7
University of Southern Denmark
Polesie, S, Gillstedt, M, Schmidt, S A J, Egeberg, A, Pottegård, A & Kristensen, K 2023, ' Use of methotrexate and risk of skin cancer : a nationwide case-control study ', British Journal of Cancer, vol. 128, no. 7, pp. 1311-1319 . https://doi.org/10.1038/s41416-023-02172-7
Background Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the association between the use of MTX and the risk of basal cell carcinoma (BCC), cutaneous squamous cell carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe8b603470a2a20d40f9e9a7b096078a
https://portal.findresearcher.sdu.dk/da/publications/bbaa4389-a76d-425d-8139-d708b71a92d5
https://portal.findresearcher.sdu.dk/da/publications/bbaa4389-a76d-425d-8139-d708b71a92d5
Autor:
Emiliana Rodriguez, Assunta Caruso, Jennifer Palomo, Sylvain Lemeille, Jérémie David Goldstein, Esen Yonca Bassoy, Cem Gabay
Publikováno v:
Life Science Alliance, Vol. 3, No 6 (2020) P. e202000688
Life Science Alliance
Life Science Alliance
IL-36 signaling in keratinocytes is crucial for Aldara-induced psoriasis-like dermatitis by controlling IL-23/IL-17A/IL-22 production and neutrophil recruitment at the third day of treatment.
IL-36R signaling plays an important role in the patho
IL-36R signaling plays an important role in the patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a62d02acb1723881951d4e669a8c3fa3
https://archive-ouverte.unige.ch/unige:154632
https://archive-ouverte.unige.ch/unige:154632
Autor:
Alexander A. Navarini, Curdin Conrad, Alessio Mylonas, Anne-Karine Lapointe, Jeremy Di Domizio, Olivier Demaria, Michel Gilliet, Cyrine Belkhodja, Lars E. French, Maxime Vernez
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications
Nature communications, vol. 9, no. 1, pp. 25
Nature Communications
Nature communications, vol. 9, no. 1, pp. 25
Although anti-tumor necrosis factor (TNF) agents are highly effective in the treatment of psoriasis, 2–5% of treated patients develop psoriasis-like skin lesions called paradoxical psoriasis. The pathogenesis of this side effect and its distinction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbc7decb248c10970a313c075620f0f
https://doaj.org/article/180fc992d72e4fcbbf1d606055e86015
https://doaj.org/article/180fc992d72e4fcbbf1d606055e86015
Publikováno v:
European Journal of Dermatology, Vol. 28, No 5 (2018) pp. 702-704
We describe the case of a 44-year-old woman with an invasive ductal carcinoma of the left breast (Stage G3, pT2 pN0[sn] MX, ROe Allred 7, RPg Allred 6 and 7, Mib1 30%, HER-2 amplification), with tumourectomy and sentinel nodes showing lymphatic but n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::b6224dc98cacaca24ca183e3cffc130a
https://archive-ouverte.unige.ch/unige:123861
https://archive-ouverte.unige.ch/unige:123861
Rituximab is a chimeric monoclonal therapeutic antibody which causes depletion of CD20-positive B cells. Apart from its apparent efficacy in the treatment of non-Hodgkin lymphoma and of several rheumatic diseases, it is associated with adverse events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::68c1f2e9f8ff477484f0120e9954f14a
http://olympias.lib.uoi.gr/jspui/handle/123456789/20815
http://olympias.lib.uoi.gr/jspui/handle/123456789/20815
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.